| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |